15th Annual APG: Highlights from the Anti-Money laundering Conference
UNPR Report, Istanbul Turkey | 17th June 2024The 15th Annual...
Getting ready for EMA’s website relaunch on 5 December 2023
The European Medicines Agency (EMA) is relaunching its corpo...
EMA encourages companies to submit type I variations for 2023 in November 2023
EMA is advising marketing authorisation holders to submit ty...
Revised transparency rules for the EU Clinical Trials Information System (CTIS)
EMA has adopted revised transparency rules for the publicati...
Technology has been changing the world rapidly
Technology has been changing the world rapidly for centuries...
EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep
EMA’s human medicines committee (CHMP) has recommended not r...
Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
EMA’s human medicines committee (CHMP) has recommended autho...
Revocation of authorisation for sickle cell disease medicine Adakveo
On 26 May 2023, EMA’s human medicines committee (CHMP) recom...
First RSV vaccine to protect infants up to 6 months of age and older adults
EMA has recommended granting a marketing authorisation in th...
OPPO Technologies Empower Global Fans to Immerse in the Excitement of Sports
t’s only July and sports fans around the world can already c...
ACT EU: creating a better environment for clinical trials through collaboration
List item News: ACT EU: creating a better environment for cl...
How artificial intelligence is changing the world?
Artificial intelligence has been one of the most talked-abou...
EMA business hours over Ascension Day holidays, 18 and 19 May
The European Medicines Agency's (EMA) office is closed from ...
First vaccine to protect older adults from respiratory syncytial virus (RSV) infection
EMA has recommended a marketing authorisation in the Europea...
New features further strengthen Priority Medicines scheme (PRIME)
EMA is introducing a number of new features to the PRIority ...